Ipamorelin vs Sermorelin
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
PubMed paper counts, ClinicalTrials.gov listings, and regulatory context—aggregated from public databases.
GH release
A selective growth-hormone secretagogue peptide—stimulates GH with less appetite spike than older GHRPs.
Ipamorelin binds ghrelin receptors and triggers pituitary GH release without strongly raising cortisol or prolactin. Clinics pair it with CJC-1295 for anti-aging and body-composition goals. Not FDA-approved for OTC use; …
GH release
A GHRH analog that prompts the pituitary to release growth hormone—often stacked with GHRP peptides in clinic and research conversations.
Sermorelin mimics the first 29 amino acids of growth-hormone-releasing hormone. It stimulates pulsatile GH release rather than supplying GH directly. It was FDA-approved as a diagnostic (Geref) but is widely discussed of…
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context. Ipamorelin is categorized as GH release; Sermorelin as GH release. Ipamorelin: A selective growth-hormone secretagogue peptide—stimulates GH with less appetite spike than older GHRPs. Sermorelin: A GHRH analog that prompts the pituitary to release growth hormone—often stacked with GHRP peptides in clinic and research conversations.
No. They are different molecules with distinct names on labels and in research databases. Always match the full INCI or drug name—not a nickname on the front of the package.
Neither page is medical or anti-doping advice. Research peptides discussed in fitness communities may be prohibited in tested sport or unavailable as OTC supplements. Verify WADA lists and talk to a clinician.